Appropriations

;

From the office of Rep. Maxine Waters: Congresswoman Maxine Waters introduces legislation to prevent the spread of HIV in honor of the U.S. Conference on HIV/AIDS

Sep 4, 2025

“While we strongly support the legislation that requires payers to cover PrEP for people who have insurance, ensuring sufficient and stable funding for the CDC so that health departments, community-based organizations and other grantees can implement HIV and hepatitis prevention programs nationwide is also vitally important,” said Carl Schmid, Executive Director of the HIV+Hepatitis Policy Institute. “We commend Congresswoman Waters and her colleagues for introducing these bills and urge the Congress to support them so that we can eventually end HIV and hepatitis in the United States.”

read more

House Republicans Go Way Beyond President’s Budget by Ending all HIV Prevention & Slash AIDS Care by 20%

Sep 1, 2025

This is not a bill for making America healthy again, but a disastrous bill that will reignite HIV in the United States. We urge Congress to reject these reckless cuts. Eliminating all HIV prevention means the end of state and local testing and surveillance programs, educational programs, and linkage to lifesaving care and treatment, along with PrEP. It will translate into an increased number of new HIV infections, which will be costlier to treat in the long run. At a time when we have the tools to prevent HIV, including new long-acting forms of PrEP, we must not abandon the bipartisan progress our nation has made in combatting HIV.

read more

Senate Appropriators Reject Trump HIV Prevention Budget Cuts, While Maintaining Care, Treatment, and PrEP

Jul 31, 2025

Today, on a bipartisan basis, the Senate Appropriations Committee rejected the Trump administration’s proposed elimination of CDC’s HIV prevention and surveillance programs. On a vote of 26 to 3, the Committee approved the Fiscal Year 2026 Labor, HHS Appropriations bill that maintains funding for existing domestic HIV prevention along with the care, treatment, and PrEP programs that were included in the president’s budget.

read more

FDA Approves Twice-Yearly HIV Prevention Drug

Jun 18, 2025

Today marks a monumental advance in HIV prevention. Congratulations to the many researchers who spent nineteen years to get to today’s approval, backed up by the long-term investment needed to get the drug to market. Long-acting PrEP is now not only effective for up to six months but also improves adherence and will reduce HIV infections—if people are aware of it and payers, including private insurers, cover it without cost-sharing as a preventive service.

read more

Sens. Cassidy & Van Hollen introduce historic bill to eliminate hepatitis C

Jun 4, 2025

We deeply thank Chairman Cassidy and Senator Van Hollen for their bipartisan leadership and dedication to eliminating hepatitis C. It has been unacceptable that people with hepatitis C have had to overcome so many discriminatory barriers instituted by state Medicaid programs and insurers to access hepatitis C curative drugs over the past twelve years since the first drug was approved. Additionally, our government has failed to invest in the public health infrastructure needed to increase awareness, testing, and linkage to care and the curative drugs. This bill, if enacted, will finally provide the necessary resources to ensure that more people are diagnosed and linked to no-cost treatment so that we can eventually eliminate hepatitis C.

read more

Search

Press Release Tags

ACA Appropriations Biden administration CDC Congress Copay accumulators Copay assistance Cost-sharing COVID-19 Drug Pricing FDA Gay men healthcare Hepatitis Hepatitis B Hepatitis C hepatits HIV HIV Prevention hous housing insurer Insurers LGBT Medicaid Medicare Part D NAIC NIH PBMs PrEP Prescription Drugs prevention Private Insurance Ryan White Ryan White Program state Syringe services Testing transparency Treatment Trump administration

Recent Press Releases

Pin It on Pinterest